Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 8, 2016
Total Value: $629.6B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Shire Plc | 409,858 | $26.6B | 4.2% | $64889.04 | — | SPONSORED ADR | 82481R106 |
| LLY | Eli Lilly & Co | 255,000 | $20.47B | 3.3% | $60.32 | +13.7% | COM | 532457108 |
| — | Alexion Pharmaceuticals Inc | 161,702 | $19.81B | 3.1% | $140.26 | — | COM | 015351109 |
| — | Celgene Corp | 186,000 | $19.44B | 3.1% | $106.40 | — | COM | 151020104 |
| — | Pfizer Inc | 555,355 | $18.81B | 3.0% | $33870.00 | — | COM | 717081102 |
| — | Allergan Plc | 79,500 | $18.31B | 2.9% | $79855.93 | — | SHS | G0177J108 |
| UNH | Unitedhealth Group Inc | 130,000 | $18.2B | 2.9% | $104.82 | +15.0% | COM | 91324P102 |
| BIIB | Biogen Inc | 57,000 | $17.84B | 2.8% | $263.83 | +12.3% | COM | 09062X103 |
| INCY | Incyte Corp | 185,000 | $17.44B | 2.8% | $72.96 | +15.5% | COM | 45337C102 |
| — | Gilead Sciences Inc | 207,304 | $16.4B | 2.6% | $79120.00 | — | COM | 375558102 |
| — | Medtronic Plc | 169,078 | $14.61B | 2.3% | $86400.00 | — | SHS | G5960L102 |
| CVS | Cvs Health Corp | 160,000 | $14.24B | 2.3% | $69.15 | +2.5% | COM | 126650100 |
| BMRN | Biomarin Pharmaceutical Inc | 140,000 | $12.95B | 2.1% | $86.90 | +8.4% | COM | 09061G101 |
| BMY | Bristol-Myers Squibb Co | 237,000 | $12.78B | 2.0% | $42.28 | +9.1% | COM | 110122108 |
| MRK | Merck & Co. Inc. | 200,000 | $12.48B | 2.0% | $43.73 | 0.0% | COM | 58933Y105 |
| TEVA | Teva Pharmaceutical-Sp Adr | 270,000 | $12.42B | 2.0% | $46010.00 | — | SHS | 881624209 |
| REGN | Regeneron Pharmaceuticals | 29,500 | $11.86B | 1.9% | $381.83 | +4.5% | COM | 75886F107 |
| ZBH | Zimmer Biomet Holdings Inc | 85,000 | $11.05B | 1.8% | $95.13 | +20.3% | COM | 98956P102 |
| — | Cigna Corp | 84,000 | $10.95B | 1.7% | $132.89 | — | COM | 125509109 |
| — | Abiomed Inc | 85,000 | $10.93B | 1.7% | $74.57 | — | COM | 003654100 |
| — | Ariad Pharmaceuticals Inc | 675,000 | $9.241B | 1.5% | $1020.28 | — | COM | 04033A100 |
| AMGN | Amgen Inc | 55,000 | $9.175B | 1.5% | $113.59 | +12.4% | COM | 031162100 |
| ALNY | Alnylam Pharmaceuticals Inc | 130,000 | $8.811B | 1.4% | $75.18 | -6.2% | COM | 02043Q107 |
| — | Anthem Inc | 67,434 | $8.45B | 1.3% | $125310.01 | — | COM | 036752102 |
| HCA | Hca Holdings Inc | 110,000 | $8.319B | 1.3% | $70.96 | +0.3% | COM | 40412C101 |
| ALKS | Alkermes Plc | 175,599 | $8.258B | 1.3% | $46.17 | +3.0% | SHS | G01767105 |
| — | Express Scripts Holding Co | 111,000 | $7.829B | 1.2% | $81.32 | — | COM | 30219G108 |
| EXEL | Exelixis Inc | 600,000 | $7.674B | 1.2% | $5.30 | +103.9% | COM | 30161Q104 |
| JAZZ | Jazz Pharmaceuticals Plc | 60,000 | $7.289B | 1.2% | $157.17 | -14.2% | SHS | G50871105 |
| — | Endo International Plc | 360,200 | $7.258B | 1.2% | $29.08 | — | SHS | G30401106 |
| HOLX | Hologic Inc | 180,000 | $6.989B | 1.1% | $32.75 | +15.3% | COM | 436440101 |
| VRTX | Vertex Pharmaceuticals Inc | 80,013 | $6.978B | 1.1% | $100.31 | -5.8% | COM | 92532F100 |
| ABBV | Abbvie Inc | 110,000 | $6.938B | 1.1% | $39.86 | +10.2% | COM | 00287Y109 |
| — | Nektar Therapeutics | 390,000 | $6.7B | 1.1% | $11.22 | — | COM | 640268108 |
| SUPN | Supernus Pharmaceuticals Inc | 270,000 | $6.677B | 1.1% | $8.66 | +161.3% | COM | 868459108 |
| EW | Edwards Lifesciences Corp | 55,000 | $6.631B | 1.1% | $23.73 | +58.7% | COM | 28176E108 |
| — | Horizon Pharma Plc | 365,000 | $6.617B | 1.1% | $18.54 | — | SHS | G4617B105 |
| — | Zeltiq Aesthetics Inc | 160,000 | $6.275B | 1.0% | $29.38 | — | COM | 98933Q108 |
| DXCM | Dexcom Inc | 65,000 | $5.698B | 0.9% | $14.22 | +56.4% | COM | 252131107 |
| — | Endologix Inc | 435,000 | $5.568B | 0.9% | $12.10 | — | COM | 29266S106 |
| XNCR | Xencor Inc | 225,000 | $5.51B | 0.9% | $14.34 | +47.6% | COM | 98401F105 |
| CNC | Centene Corp | 80,000 | $5.357B | 0.9% | $30.22 | +14.9% | COM | 15135B101 |
| — | Lion Biotechnologies Inc | 650,000 | $5.349B | 0.8% | $8.37 | — | COM | 53619R102 |
| — | Walgreens Boots Alliance Inc | 65,000 | $5.24B | 0.8% | $85.15 | — | COM | 931427108 |
| — | Nevro Corp | 49,300 | $5.146B | 0.8% | $67.31 | — | COM | 64157F103 |
| — | Rigel Pharmaceuticals Inc | 1,400,000 | $5.138B | 0.8% | $1443.95 | — | COM | 766559603 |
| — | Kite Pharma Inc | 90,000 | $5.027B | 0.8% | $12452.22 | — | COM | 49803L109 |
| — | Aetna Inc | 42,000 | $4.849B | 0.8% | $104.69 | — | COM | 00817Y108 |
| OMCL | Omnicell Inc | 118,537 | $4.54B | 0.7% | $31.17 | +19.6% | COM | 68213N109 |
| HUM | Humana Inc | 25,000 | $4.422B | 0.7% | $169.43 | -5.2% | COM | 444859102 |
| COR | Amerisourcebergen Corp | 53,000 | $4.281B | 0.7% | $62.62 | +2.6% | COM | 03073E105 |
| CAH | Cardinal Health Inc | 55,000 | $4.274B | 0.7% | $60.16 | +2.2% | COM | 14149Y108 |
| MGNX | Macrogenics Inc | 140,000 | $4.187B | 0.7% | $25.02 | +18.9% | COM | 556099109 |
| MCK | Mckesson Corp | 25,000 | $4.169B | 0.7% | $191.15 | -9.4% | COM | 58155Q103 |
| — | Laboratory Crp Of Amer Hldgs | 30,000 | $4.124B | 0.7% | $121.84 | — | COM | 50540R409 |
| — | Radius Health Inc | 75,000 | $4.057B | 0.6% | $31.44 | — | COM | 750469207 |
| TMO | Thermo Fisher Scientific Inc | 25,000 | $3.977B | 0.6% | $150.09 | 0.0% | COM | 883556102 |
| — | Cempra Inc | 161,000 | $3.896B | 0.6% | $33.87 | — | COM | 15130J109 |
| — | Array Biopharma Inc | 550,000 | $3.712B | 0.6% | $2212.32 | — | COM | 04269X105 |
| UHS | Universal Health Services-B | 30,000 | $3.697B | 0.6% | $121.65 | 0.0% | COM | 913903100 |
| DVA | Davita Inc | 55,000 | $3.634B | 0.6% | $70.40 | 0.0% | COM | 23918K108 |
| — | Nxstage Medical Inc | 145,300 | $3.631B | 0.6% | $21.68 | — | COM | 67072V103 |
| — | Cooper Cos Inc/The | 20,000 | $3.585B | 0.6% | $171.80 | — | COM | 216648402 |
| CHRS | Coherus Biosciences Inc | 131,357 | $3.518B | 0.6% | $18.77 | +45.3% | COM | 19249H103 |
| — | Revance Therapeutics Inc | 210,000 | $3.404B | 0.5% | $23.00 | — | COM | 761330109 |
| PRGO | Perrigo Co Plc | 35,000 | $3.232B | 0.5% | $133.85 | -31.2% | SHS | G97822103 |
| — | Dynavax Technologies Corp | 300,000 | $3.147B | 0.5% | $5255.39 | — | COM | 268158201 |
| — | Chimerix Inc | 550,000 | $3.047B | 0.5% | $10.40 | — | COM | 16934W106 |
| HALO | Halozyme Therapeutics Inc | 250,000 | $3.02B | 0.5% | $16.27 | -37.2% | COM | 40637H109 |
| — | Portola Pharmaceuticals Inc | 120,805 | $2.743B | 0.4% | $3001.81 | — | COM | 737010108 |
| — | Neuroderm Ltd | 144,546 | $2.673B | 0.4% | $16.25 | — | SHS | M74231107 |
| — | Keryx Biopharmaceuticals | 500,111 | $2.656B | 0.4% | $536.52 | — | COM | 492515101 |
| PODD | Insulet Corp | 57,000 | $2.334B | 0.4% | $34.93 | +13.2% | COM | 45784P101 |
| — | Rite Aid Corp | 300,000 | $2.307B | 0.4% | $7690.00 | — | COM | 767754104 |
| — | Tesaro Inc | 21,500 | $2.155B | 0.3% | $100240.00 | — | COM | 881569107 |
| — | Achillion Pharmaceuticals | 266,000 | $2.155B | 0.3% | $9.71 | — | COM | 00448Q201 |
| — | Fibrogen Inc | 104,000 | $2.153B | 0.3% | $25.32 | — | COM | 31572Q808 |
| — | Adamas Pharmaceuticals Inc | 130,000 | $2.133B | 0.3% | $15.14 | — | COM | 00548A106 |
| — | Intra-Cellular Therapies Inc | 135,000 | $2.057B | 0.3% | $2274.16 | — | COM | 46116X101 |
| NBIX | Neurocrine Biosciences Inc | 40,000 | $2.026B | 0.3% | $39.68 | +25.5% | COM | 64125C109 |
| ESPR | Esperion Therapeutics Inc | 130,000 | $1.8B | 0.3% | $20.34 | -44.3% | COM | 29664W105 |
| — | Tandem Diabetes Care Inc | 234,000 | $1.792B | 0.3% | $829.71 | — | COM | 875372104 |
| JNJ | Johnson & Johnson | 15,000 | $1.772B | 0.3% | $93.58 | 0.0% | COM | 478160104 |
| — | Intercept Pharmaceuticals In | 10,000 | $1.646B | 0.3% | $164590.00 | — | COM | 45845P108 |
| ACAD | Acadia Pharmaceuticals Inc | 50,000 | $1.591B | 0.3% | $25.97 | +30.6% | COM | 004225108 |
| — | Valeant Pharmaceuticals Inte | 50,000 | $1.228B | 0.2% | $39.55 | — | COM | 91911K102 |
| — | Tetraphase Pharmaceuticals I | 300,000 | $1.149B | 0.2% | $17.20 | — | COM | 88165N105 |
| — | Regulus Therapeutics Inc | 300,000 | $990M | 0.2% | $4.98 | — | COM | 75915K101 |
| — | Anthera Pharmaceuticals Inc | 300,000 | $945M | 0.2% | $3.60 | — | COM | 03674U201 |
| — | Adverum Biotechnologies Inc | 154,006 | $633M | 0.1% | $3.16 | — | COM | 00773U108 |
| — | Catabasis Pharmaceuticals In | 100,000 | $616M | 0.1% | $10.91 | — | COM | 14875P107 |
| MD | Mednax Inc | 9,000 | $596M | 0.1% | $68.74 | -0.5% | COM | 58502B106 |
| — | Orexigen Therapeutics Inc | 120,000 | $398M | 0.1% | $3320.00 | — | COM | 686164302 |
| — | Mirati Therapeutics Inc | 50,000 | $331M | 0.1% | $31.48 | — | COM | 60468T105 |
| — | Concert Pharmaceuticals Inc | 30,099 | $304M | 0.0% | $11.23 | — | COM | 206022105 |
| OCUL | Ocular Therapeutix Inc | 40,000 | $275M | 0.0% | $7.57 | -19.5% | COM | 67576A100 |
| WFC | Wells Fargo & Co | 4,522 | $200M | 0.0% | $36.83 | 0.0% | COM | 949746101 |
| QCOM | Qualcomm Inc | 2,869 | $197M | 0.0% | $46.91 | 0.0% | COM | 747525103 |
| CAT | Caterpillar Inc | 2,178 | $193M | 0.0% | $66.01 | 0.0% | COM | 149123101 |
| GKOS | Glaukos Corp | 5,100 | $192M | 0.0% | $23.15 | +43.0% | COM | 377322102 |
| HAL | Halliburton Co | 4,231 | $190M | 0.0% | $36.37 | 0.0% | COM | 406216101 |
| XOM | Exxon Mobil Corp | 2,102 | $183M | 0.0% | $58.54 | 0.0% | COM | 30231G102 |
| IBM | Intl Business Machines Corp | 1,143 | $182M | 0.0% | $101.76 | 0.0% | COM | 459200101 |
| MSFT | Microsoft Corp | 3,140 | $181M | 0.0% | $50.29 | 0.0% | COM | 594918104 |
| JPM | Jpmorgan Chase & Co | 2,688 | $179M | 0.0% | $50.85 | 0.0% | COM | 46625H100 |
| F | Ford Motor Co | 14,611 | $176M | 0.0% | $7.68 | 0.0% | COM | 345370860 |
| — | Threshold Pharmaceuticals | 201,537 | $137M | 0.0% | $4.08 | — | COM | 885807206 |